NFKB1 and neoplasm: These examples illustrate the importance of the therapeutic targeting of NF-κB is significant due to its ability to alter the TME, reduce tumor resistance to conventional therapies, and improve the outcomes of immunotherapeutic approaches (Karin, 2006; Greten and Karin, 2004; Gilmore and Herscovitch, 2006).